Trials / Completed
CompletedNCT05286970
A Clinical Study of AK115 in Healthy Subjects
A Phase I Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamic Characteristics of Single Dose Subcutaneous Administration of AK115 in Healthy Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 42 (actual)
- Sponsor
- Akeso · Industry
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
This trial is a randomized, double-blind, placebo-controlled dose escalation phase I trial following single dose subcutaneous administration of AK115 injection. It aims to evaluate the safety, pharmacokinetic characteristics, pharmacodynamic effect and immunogenicity of single dose of AK115 injection in healthy subjects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | AK115 | Abdominal subcutaneous injection |
| DRUG | Placebo | Abdominal subcutaneous injection |
Timeline
- Start date
- 2022-03-18
- Primary completion
- 2022-09-28
- Completion
- 2022-09-28
- First posted
- 2022-03-18
- Last updated
- 2025-02-28
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05286970. Inclusion in this directory is not an endorsement.